BACKGROUND: In 2010, the Melody transcatheter pulmonary valve (TPV) received Food and Drug Administration approval for treatment of dysfunctional right ventricular outflow tract conduits in patients ≥30 kg. Limited data are available regarding use of this device in smaller patients.
METHODS AND RESULTS: We evaluated technical and short-term clinical outcomes of 25 patients
CONCLUSIONS: Percutaneous TPV replacement can be performed in small children with good procedural and early hemodynamic results in the majority of patients.
Mendeley saves you time finding and organizing research
Choose a citation style from the tabs below